| Literature DB >> 27029613 |
Elizabeth R Figueroa1, J Stephen Yan1, Nicolette K Chamberlain-Simon1, Adam Y Lin1, Aaron E Foster2, Rebekah A Drezek3.
Abstract
BACKGROUND: Gold nanoparticles (AuNPs) have shown great promise as scaffolds for gene therapy vectors due to their attractive physiochemical properties which include biocompatibility, ease of functionalization via the nearly covalent gold-sulfur dative bond, and surface plasmon optical properties. Previously, we synthesized stable AuNP-polyamidoamine (AuPAMAM) conjugates and showed their success in vitro as non-viral gene delivery vectors.Entities:
Keywords: Gene therapy; Nanoparticle; Nanotechnology
Mesh:
Substances:
Year: 2016 PMID: 27029613 PMCID: PMC4815207 DOI: 10.1186/s12951-016-0178-9
Source DB: PubMed Journal: J Nanobiotechnology ISSN: 1477-3155 Impact factor: 10.435
Fig. 1Synthetic parameters investigated. a AuPAMAM surface density. b PAMAM core and terminal chemistry. c SAM composition
Fig. 2UV-Vis spectra showing peak shifts upon AuSAM formation
AuPAMAM synthetic parameters and nomenclature
| AuPAMAM nomenclature | PAMAM molar excess | PAMAM chemistry | SAM composition |
|---|---|---|---|
| Standard | 50 | EDA core | MUA |
| Varying PAMAM molar excess | |||
| MUA-EDA10 | 10 | EDA core | MUA |
| MUA-EDA25 | 25 | EDA core | MUA |
| MUA-EDA100 | 100 | EDA core | MUA |
| Varying PAMAM chemistry | |||
| MUA-DAH50 | 50 | DAH core | MUA |
| MUA-Cys50 | 50 | Cystamine core | MUA |
| MUA-OH/NH250 | 50 | 1:1 OH:NH2 | MUA |
| Varying SAM composition | |||
| MHA-EDA50 | 50 | EDA core | MHA |
| sMUA-EDA50 | 50 | EDA core | 1:9 MUA:MUOH |
| PEG-EDA50 | 50 | EDA core | PEG |
| Optimal AuPAMAM vectors | |||
| MHA-DAH50 | 50 | DAH core | MHA |
| PEG-DAH50 | 50 | DAH core | PEG |
| PEG-DAH100 | 100 | DAH core | PEG |
Fig. 3Characterization from varying PAMAM Concentration. a AuPAMAM/DNA complex sizes and polydispersity as measured by DLS. b Cell viability after complex exposure. c Percent transfection and mean fluorescence intensity
Fig. 4Characterization from varying PAMAM Chemistry. a AuPAMAM/DNA complex sizes and polydispersity. b Cell viability after complex exposure. c Percent transfection and mean fluorescence intensity
Fig. 5Characterization from varying SAM Composition. a AuPAMAM/DNA complex sizes and polydispersity. b Cell viability after complex exposure. c Percent transfection and mean fluorescence intensity
Fig. 6Optimization of synthesis parameters; a AuPAMAM/DNA complex sizes and polydispersity. b Cell viability after complex exposure. c Percent transfection and mean fluorescence intensity